IgG / Bruce Freimark1 1 Peregrine Pharmaceuticals Inc. / /
Currency
pence / /
Facility
UT Southwestern Medical Center / University of California / /
IndustryTerm
optical imaging / ex vivo tumor imaging / imaging / /
MedicalCondition
C. Tumors / tumor / BT474 breast tumors / Cancer / tumors / B. Quantified fluorescent tumor ROI / human breast tumors / male SCID / breast tumors / non-small cell lung cancer / SCID / Prostate Tumors / orthotopic BT474 breast tumors / pancreatic cancer / /
MedicalTreatment
chemotherapy / /
Organization
I.V. administration / Michael Brown/Process Science Department of Peregrine / UT Southwestern Medical Center / University of California / Irvine / DC DP / /
Person
Connie Chang / Michael Brown / Kyle Schlunegger (Peregrine) / Anita Kavlie (Affitech) / Phillip Thorpe / Steven King (Peregrine) / /
# P731 Imaging of Human Tumor Xenografts in Mice Using Near-Infrared FluorescentLabeled Phosphatidylserine-Targeting Antibodies Jian Gong1, Richard Archer1, Linda Him2, Christopher Hughes2, Bruce Freimark1 1 Peregrine P